Pulmonary complications in pregnancy: Emboli and other diseases

Elana M. Oberstein, Amanda Marder, Shannon Pitts, Marilyn K Glassberg Csete

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Pulmonary embolism (PE) and amniotic fluid embolism are uncommon complications during pregnancy, but they nonetheless require rapid diagnosis and treatment because of their high mortality rates. Heparin is the treatment of choice for PE, and prophylactic heparin is indicated for women who had PE during a previous pregnancy. Low molecular weight heparin is a safe and effective alternative to unfractionated heparin. Women with amniotic fluid embolism typically present with sudden dyspnea and hypotension. The mortality rate is 50% to 60% within 1 hour of the onset of symptoms. Women who have cystic fibrosis or pulmonary lymphangioleiomyomatosis often experience a decline in pulmonary function during pregnancy, while those with sarcoidosis may show improvement. Regardless of the pulmonary disorder, the goal is to avoid hypoxemia, which can result in profound adverse maternal and fetal effects.

Original languageEnglish
Pages (from-to)175-181
Number of pages7
JournalJournal of Respiratory Diseases
Volume23
Issue number3
StatePublished - Jan 1 2002

Fingerprint

Pregnancy Complications
Embolism
Amniotic Fluid Embolism
Pulmonary Embolism
Heparin
Lung
Lymphangioleiomyomatosis
Pregnancy
Mortality
Low Molecular Weight Heparin
Sarcoidosis
Cystic Fibrosis
Dyspnea
Hypotension
Therapeutics

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Pulmonary complications in pregnancy : Emboli and other diseases. / Oberstein, Elana M.; Marder, Amanda; Pitts, Shannon; Glassberg Csete, Marilyn K.

In: Journal of Respiratory Diseases, Vol. 23, No. 3, 01.01.2002, p. 175-181.

Research output: Contribution to journalArticle

Oberstein, Elana M. ; Marder, Amanda ; Pitts, Shannon ; Glassberg Csete, Marilyn K. / Pulmonary complications in pregnancy : Emboli and other diseases. In: Journal of Respiratory Diseases. 2002 ; Vol. 23, No. 3. pp. 175-181.
@article{73c931239a4341e48cde0701a9b1f3d3,
title = "Pulmonary complications in pregnancy: Emboli and other diseases",
abstract = "Pulmonary embolism (PE) and amniotic fluid embolism are uncommon complications during pregnancy, but they nonetheless require rapid diagnosis and treatment because of their high mortality rates. Heparin is the treatment of choice for PE, and prophylactic heparin is indicated for women who had PE during a previous pregnancy. Low molecular weight heparin is a safe and effective alternative to unfractionated heparin. Women with amniotic fluid embolism typically present with sudden dyspnea and hypotension. The mortality rate is 50{\%} to 60{\%} within 1 hour of the onset of symptoms. Women who have cystic fibrosis or pulmonary lymphangioleiomyomatosis often experience a decline in pulmonary function during pregnancy, while those with sarcoidosis may show improvement. Regardless of the pulmonary disorder, the goal is to avoid hypoxemia, which can result in profound adverse maternal and fetal effects.",
author = "Oberstein, {Elana M.} and Amanda Marder and Shannon Pitts and {Glassberg Csete}, {Marilyn K}",
year = "2002",
month = "1",
day = "1",
language = "English",
volume = "23",
pages = "175--181",
journal = "Journal of Respiratory Diseases - For Pediatricians",
issn = "0194-259X",
publisher = "Cliggott Publishing Co.",
number = "3",

}

TY - JOUR

T1 - Pulmonary complications in pregnancy

T2 - Emboli and other diseases

AU - Oberstein, Elana M.

AU - Marder, Amanda

AU - Pitts, Shannon

AU - Glassberg Csete, Marilyn K

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Pulmonary embolism (PE) and amniotic fluid embolism are uncommon complications during pregnancy, but they nonetheless require rapid diagnosis and treatment because of their high mortality rates. Heparin is the treatment of choice for PE, and prophylactic heparin is indicated for women who had PE during a previous pregnancy. Low molecular weight heparin is a safe and effective alternative to unfractionated heparin. Women with amniotic fluid embolism typically present with sudden dyspnea and hypotension. The mortality rate is 50% to 60% within 1 hour of the onset of symptoms. Women who have cystic fibrosis or pulmonary lymphangioleiomyomatosis often experience a decline in pulmonary function during pregnancy, while those with sarcoidosis may show improvement. Regardless of the pulmonary disorder, the goal is to avoid hypoxemia, which can result in profound adverse maternal and fetal effects.

AB - Pulmonary embolism (PE) and amniotic fluid embolism are uncommon complications during pregnancy, but they nonetheless require rapid diagnosis and treatment because of their high mortality rates. Heparin is the treatment of choice for PE, and prophylactic heparin is indicated for women who had PE during a previous pregnancy. Low molecular weight heparin is a safe and effective alternative to unfractionated heparin. Women with amniotic fluid embolism typically present with sudden dyspnea and hypotension. The mortality rate is 50% to 60% within 1 hour of the onset of symptoms. Women who have cystic fibrosis or pulmonary lymphangioleiomyomatosis often experience a decline in pulmonary function during pregnancy, while those with sarcoidosis may show improvement. Regardless of the pulmonary disorder, the goal is to avoid hypoxemia, which can result in profound adverse maternal and fetal effects.

UR - http://www.scopus.com/inward/record.url?scp=0036207419&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036207419&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0036207419

VL - 23

SP - 175

EP - 181

JO - Journal of Respiratory Diseases - For Pediatricians

JF - Journal of Respiratory Diseases - For Pediatricians

SN - 0194-259X

IS - 3

ER -